New Isribs - DNL343, ABBV-CLS-7262?
IdkAnything 11 Jun 2023
These are the new orally bioavailable compounds currently undergoing clinical trials and it would be great to find a way to source them.
sponsored ad
IdkAnything 11 Jul 2023
Hip 15 Jul 2023
ISRIB may cause dangerous cardiac events, see this report of a person who was hospitalised after collapsing in his bathroom with heart issues after taking ISRIB.
IdkAnything 16 Jul 2023
Hip 17 Jul 2023
Abbv-cls-7262, one of the first isribs designed for human consumption, is over 8 months into human trials, and has shown no major adverse events while having measurable biomarkers isr inhibition. The only disappointment is none of the trials have published whether it has any beneficial effects yet. No one knows. As for the previous isribs, we only have anecdotes of people that may have never gotten absorption in the first place.
I used to be in an ISRIB Telegram group, where lots of people were taking ISRIB. Most seemed fine, but I think a few reported pangs in their heart, and as mentioned, one collapsed and had to be rushed to hospital.